DERMAdoctor, Inc.

DERMAdoctor, Inc. is a skincare company specializing in dermatologist-developed products that address various skin concerns. Its innovative approach focuses on high-quality, effective solutions for healthier skin. Founded in 1998, DERMAdoctor, Inc.

is based in Riverside, US, and has positioned itself as a key player in the skincare industry. The company was founded by Audrey Kunin. In September 2021, NovaBay Pharmaceuticals, Inc. acquired DERMAdoctor for USD 15 million, with USD 12 million paid upfront and an additional USD 3 million contingent on future financial targets.

This acquisition aims to bolster NovaBay's presence in the US beauty market. The company has participated in 2 funding deals, with the latest occurring in 2021. DERMAdoctor specializes in skincare formulations developed through a women-led, dermatologist-driven approach, focusing on effective solutions for various skin concerns such as keratosis pilaris, acne, psoriasis, and sensitive skin. Core products include the KP Duty Body Scrub and KP Moisturizing Lotion, which utilize organic ingredients and adhere to cruelty-free practices, aiming to improve the skin's appearance.

The company primarily serves clients in the United States, Europe, and Australia, addressing real skin issues with innovative skincare solutions. DERMAdoctor generates revenue through direct-to-consumer sales via its online platform and retail partnerships. Key products like the KP Duty Body Scrub and Kakadu C Vitamin C Serum significantly contribute to overall sales. The company employs a subscription model to encourage repeat purchases, allowing customers to receive their favorite products regularly, catering to consumers who value dermatologist-developed skincare.

Following the acquisition by NovaBay Pharmaceuticals, Inc. , the management team of DERMAdoctor, including President Dr. Jeff Kunin, will continue to lead the company, focusing on expanding product offerings and market presence. Specific plans include launching new products designed to meet evolving customer needs, with expected launches in the upcoming fiscal years.

Further, DERMAdoctor aims to expand into new geographic markets, leveraging the financial support from the acquisition to enhance its reach in the US beauty market and potentially explore opportunities in Asia by 2023.